Literature DB >> 23018751

Sickle cell disease incidence among newborns in New York State by maternal race/ethnicity and nativity.

Ying Wang1, Joseph Kennedy, Michele Caggana, Regina Zimmerman, Sanil Thomas, John Berninger, Katharine Harris, Nancy S Green, Suzette Oyeku, Mary Hulihan, Althea M Grant, Scott D Grosse.   

Abstract

PURPOSE: Sickle cell disease is estimated to occur in 1:300-400 African-American births, with higher rates among immigrants from Africa and the Caribbean, and is less common among Hispanic births. This study determined sickle cell disease incidence among New York State newborns stratified by maternal race/ethnicity and nativity.
METHODS: Newborns with confirmed sickle cell disease born to New York State residents were identified by the New York State newborn screening program for the years 2000-2008 and matched to birth records to obtain birth and maternal information. Annual incidence rates were computed and bivariate analyses were conducted to examine associations with maternal race/ethnicity and nativity.
RESULTS: From 2000 to 2008, 1,911 New York State newborns were diagnosed with sickle cell disease and matched to the birth certificate files. One in every 1,146 live births was diagnosed with sickle cell disease. Newborns of non-Hispanic black mothers accounted for 86% of sickle cell disease cases whereas newborns of Hispanic mothers accounted for 12% of cases. The estimated incidence was 1:230 live births for non-Hispanic black mothers, 1:2,320 births for Hispanic mothers, and 1:41,647 births for non-Hispanic white mothers. Newborns of foreign-born non-Hispanic black mothers had a twofold higher incidence of sickle cell disease than those born to US-born non-Hispanic black mothers (P < 0.001).
CONCLUSION: This study provides the first US estimates of sickle cell disease incidence by maternal nativity. Women born outside the United States account for the majority of children with sickle cell disease born in New York State. Such findings identify at-risk populations and inform outreach activities that promote ongoing, high-quality medical management to affected children.

Entities:  

Mesh:

Year:  2012        PMID: 23018751      PMCID: PMC4453875          DOI: 10.1038/gim.2012.128

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  19 in total

1.  Newborn screening follow-up within the lifespan context: Michigan's experience.

Authors:  Violanda Grigorescu; Mary J Kleyn; Steven J Korzeniewski; William I Young; Wanda Whitten-Shurney
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

2.  Awareness of sickle cell among people of reproductive age: Dominicans and African Americans in northern Manhattan.

Authors:  Saira Siddiqui; Kelly Schunk; Milagros Batista; Francisca Adames; Peggy Ayala; Benjamin Stix; Jacqueline Rodriguez; Mary McCord; Nancy S Green
Journal:  J Urban Health       Date:  2012-02       Impact factor: 3.671

3.  Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state.

Authors:  F W Lorey; J Arnopp; G C Cunningham
Journal:  Genet Epidemiol       Date:  1996       Impact factor: 2.135

4.  Data linkage methods used in maternally-linked birth and infant death surveillance data sets from the United States (Georgia, Missouri, Utah and Washington State), Israel, Norway, Scotland and Western Australia.

Authors:  A A Herman; B J McCarthy; J M Bakewell; R H Ward; B A Mueller; N E Maconochie; A W Read; P Zadka; R Skjaerven
Journal:  Paediatr Perinat Epidemiol       Date:  1997-01       Impact factor: 3.980

5.  Haemoglobin gene frequencies in the Jamaican population: a study in 100,000 newborns.

Authors:  G R Serjeant; B E Serjeant; M Forbes; R J Hayes; D R Higgs; H Lehmann
Journal:  Br J Haematol       Date:  1986-10       Impact factor: 6.998

6.  Positive screening and carrier results for the England-wide universal newborn sickle cell screening programme by ethnicity and area for 2005-07.

Authors:  Allison Streetly; Radoslav Latinovic; Joan Henthorn
Journal:  J Clin Pathol       Date:  2010-07       Impact factor: 3.411

7.  Newborn sickle cell disease screening: the Jamaican experience (1995-2006).

Authors:  L King; R Fraser; M Forbes; M Grindley; S Ali; M Reid
Journal:  J Med Screen       Date:  2007       Impact factor: 2.136

8.  Ethnic and gender patterns for the five congenital disorders in Texas from 1992 through 1998.

Authors:  Jamison E Strahan; Mark A Canfield; L Margaret Drummond-Borg; Susan U Neill
Journal:  Tex Med       Date:  2002-09

9.  Long-term follow-up of children with confirmed newborn screening disorders using record linkage.

Authors:  Ying Wang; Michele Caggana; Marilyn Sango-Jordan; Mingzeng Sun; Charlotte M Druschel
Journal:  Genet Med       Date:  2011-10       Impact factor: 8.822

10.  Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil.

Authors:  Antonio G Pacheco; Valeria Saraceni; Suely H Tuboi; Lawrence H Moulton; Richard E Chaisson; Solange C Cavalcante; Betina Durovni; José C Faulhaber; Jonathan E Golub; Bonnie King; Mauro Schechter; Lee H Harrison
Journal:  Am J Epidemiol       Date:  2008-10-09       Impact factor: 4.897

View more
  12 in total

1.  Quality of Life of Latino and Non-Latino Youth With Sickle Cell Disease as Reported by Parents and Youth.

Authors:  Jennel C Osborne; Nancy S Green; Arlene M Smaldone
Journal:  Hisp Health Care Int       Date:  2020-03-03

2.  Food insecurity, housing instability, and dietary quality among children with sickle cell disease: Assessment from a single urban center.

Authors:  Cristina R Fernández; Maureen Licursi; Randi Wolf; Margaret T Lee; Nancy S Green
Journal:  Pediatr Blood Cancer       Date:  2021-11-22       Impact factor: 3.167

3.  Infants with Congenital Disorders Identified Through Newborn Screening - United States, 2015-2017.

Authors:  Marci K Sontag; Careema Yusuf; Scott D Grosse; Sari Edelman; Joshua I Miller; Sarah McKasson; Yvonne Kellar-Guenther; Marcus Gaffney; Cynthia F Hinton; Carla Cuthbert; Sikha Singh; Jelili Ojodu; Stuart K Shapira
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-09-11       Impact factor: 17.586

4.  Racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer.

Authors:  Avital Harari; Ning Li; Michael W Yeh
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

5.  Mortality of New York children with sickle cell disease identified through newborn screening.

Authors:  Ying Wang; Gang Liu; Michele Caggana; Joseph Kennedy; Regina Zimmerman; Suzette O Oyeku; Ellen M Werner; Althea M Grant; Nancy S Green; Scott D Grosse
Journal:  Genet Med       Date:  2014-09-25       Impact factor: 8.822

6.  Opioid Use in Adults With Sickle Cell Disease Hospitalized During Vaso-Occlusive Crisis: A Systematic Review.

Authors:  Jennel C Osborne; Zainab Osakwe; Michelle Odlum
Journal:  J Hematol       Date:  2021-04-27

7.  Editorial: The Complexity of Reporting Race and Ethnicity in Orthopaedic Research.

Authors:  Seth S Leopold; Lee Beadling; Anthony M Calabro; Matthew B Dobbs; Mark C Gebhardt; Terence J Gioe; Paul A Manner; Raphaël Porcher; Clare M Rimnac; Montri D Wongworawat
Journal:  Clin Orthop Relat Res       Date:  2018-05       Impact factor: 4.176

8.  Newborn Screening for Sickle Cell Disease in St. Vincent and the Grenadines: Results of a Pilot Newborn Screening Program.

Authors:  Shelly-Ann Williams; Beneka Browne-Ferdinand; Ynolde Smart; Kristen Morella; Susan G Reed; Julie Kanter
Journal:  Glob Pediatr Health       Date:  2017-11-03

9.  Improving an Administrative Case Definition for Longitudinal Surveillance of Sickle Cell Disease.

Authors:  Angela B Snyder; Mei Zhou; Rodney Theodore; Maa-Ohui Quarmyne; James Eckman; Peter A Lane
Journal:  Public Health Rep       Date:  2019-04-10       Impact factor: 2.792

10.  Meeting the emerging public health needs of persons with blood disorders.

Authors:  Christopher S Parker; James Tsai; Azfar-e-Alam Siddiqi; Hani K Atrash; Lisa C Richardson
Journal:  Am J Prev Med       Date:  2014-09-19       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.